Accendra Health Inc. CEO Edward A. Pesicka to Retire; Successor Search

What Happened

• On August 10, 2026, Accendra Health, Inc. filed an 8-K announcing that Edward A. Pesicka, the Company’s President, Chief Executive Officer and a director, notified the board of his intent to retire and step down from the board by the end of 2026 (or earlier if a successor is appointed).
• The filing states Mr. Pesicka’s decision is not due to any disagreement with the Company about operations, policies or practices. The Board has begun a process to evaluate and select his successor. The company also issued a press release dated August 10, 2026 (furnished as Exhibit 99.1).

Key Details

• Filing date: August 10, 2026 (Form 8-K).
• Executive: Edward A. Pesicka — President, Chief Executive Officer & Director.
• Timing: Will step down from the Board by end of 2026, or earlier upon appointment of a successor.
• Process: Board has commenced evaluation and selection of a successor; press release furnished as Exhibit 99.1.

Why It Matters

• CEO transitions are material events because leadership changes can affect company strategy, execution and investor confidence. A planned, non-disagreement retirement and an active successor search suggest an orderly transition, but investors should watch for announcements of the successor and any related management or strategy changes.
• Monitor upcoming SEC filings and company press releases for the identity of the successor, transition timeline, and any updates on leadership or guidance that could affect the company’s operations or outlook.